Peptide-targeted diagnostics and radiotherapeutics

Accounts of Chemical Research

Volumn 42, Issue 7, 2009, Pages 958-968

  Tweedle, Michael F ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; DO3A CH2CO G 4 AMINOBENZOYL Q W A V G H L M NH2; DO3A-CH2CO-G-4-AMINOBENZOYL-Q-W-A-V-G-H-L-M-NH2; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GADOLINIUM; LUTETIUM; OLIGOPEPTIDE; PEPTIDE; RADIOPHARMACEUTICAL AGENT; TUFTSIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; HUMAN; MALE; METABOLISM; MOLECULAR GENETICS; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR; PROTEIN BINDING; RAT; SCINTISCANNING;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; CELL LINE; GADOLINIUM; HUMANS; LUTETIUM; MALE; MOLECULAR SEQUENCE DATA; NEOPLASMS; OLIGOPEPTIDES; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; PROTEIN BINDING; RADIOPHARMACEUTICALS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, G-PROTEIN-COUPLED; TUFTSIN;

EID: 67651102575     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar800215p     Document Type: Article

References (34)

1. Tweedle, M. F.; Gaughan, G.; Hagan, J. 1-Substituted-1,4,7, triscarboxymethyl- 1,4,7,10-tetraazacyclododecane and analogs. U.S. Patent No. 4,885,363, 1989.
2. Gries, H.; Rosenberg, D.; Weinman, H.-J. Diagnostic media. U.S. Patent No. 4,647,447, 1987.
3. Desreux, J. F.; Loncin, M. F.; Spirlet, M. R. Solution and solid state structures of lanthanide complexes with polyaza polyacetic macrocyclic ligands: A comparison of NMR and X-ray studies. Inorg. Chim. Acta 1984, 94, 43.
4. Cacheris, W. P.; Nickle, S. K.; Sherry, A. D. Thermodynamic study of lanthanide complexes of 1,4,7-triazacyclononane-N,N′,N″-triacetic acid and 1,4,7,10- tetraazacyclododecane-N,N′,N″,N‴- tetraacetic acid. Inorg. Chem. 1987, 26, 958-960.
5. Merbach, A. E., Toth, E., Eds. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging; Wiley: New York, 2001.
6. Unfortunately, DOTA and DO3A are used often used interchangeably. DOTA should be used for tetra-acetates and DO3A for triacetates.
7. 177Lu- labeled GRP-R agonist for systemic radiotherapy of prostate cancer. J. Nucl. Med. 2006, 47, 1144-1152. (Pubitemid 47558898)
8. Chen, J.; Linder, K. E.; Cagnolini, A.; Metcalfe, E.; Raju, N.; Tweedle, M. F.; Swenson, R. E. Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for gastrin releasing peptide receptor positive tumors. Appl. Radiat. Isotopes 2008, 66, 497-505.
9. Waser, B.; Eltschinger, V.; Linder, K.; Nunn, A.; Reubi, J. C. Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 95-100. (Pubitemid 44885559)
10. Panigone, S.; Nunn, A. D. Luttetium-177-labeled gastrin releasing peptide receptor binding analog: a novel approach to radionuclide therapy. Q. J. Nucl. Med. Mol. Imaging 2006, 50, 310-321. (Pubitemid 46157612)
11. 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues. Clin. Exp. Metastasis 2009, 26, 105-119.
12. Swenson, R. E.; Lattuada, L.; Linder, K. E.; Capalleti, E.; Raju, N.; Chen, J.; Lantry, L. E.; Thoma, R.; Arunachalum, T.; Maddelena, M. E.; Fox, J. S.; Nunn, A. D. Tweedle, M. F. Optimization of the linker between the metal chelate and the targeting peptide provided the superior properties of 177Lu-AMBA, a GRP radiotherapeutic in clinical development, Presented at the 236th ACS meeting, 2008, abstract no. 387.
13. 177Lu-DOTA-8- Aoc-BBN[7-14]NH2: An in vitro/in vivo assessment of the targetingability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nucl. Med. Biol. 2003, 30, 101-109. (Pubitemid 36293710)
14. Linder, K. E.; Metcalfe, E.; Arunachalam, T.; Chen, J.; Eaton, S. M.; Feng, W.; Fan, H.; Raju, N.; Cagnolini, A. In vitro and in vivo metabolism of Lu-AMBA, a GRPreceptor binding compound and the synthesis and characterization of its metabolites. Bioconjugate Chem., in press.
15. Bodei, L.; Ferrari, M.; Nunn, A.; Llull, J. B.; Cremonesi, M.; Martano, L.; Laurora, G.; Scardino, E.; Tiberini, S.; Bufi, G.; Eaton, S.; De Cobelli, O.; Paganelli, G. Presented at the European Association for Nuclear Medicine meeting, 2007, Copenhagen.
16. 177Lu-labeled radiotherapeutic compound and NMR structural elucidation of the ligand and its Lu and Hf complexes. Inorg. Chem. 2009, 48, 3114-3124.
17. Kumar, K.; Tweedle, M. F. Ligand basicity and rigidity control formation of macrocyclic polyaminocarboxylate complexes of Gd(III). Inorg. Chem. 1993, 32, 4193-4199.
18. Sato, A. K.; Sexton, D. J.; Morganelli, L. A.; Cohen, E. H.; Wu, Q. L.; Conley, G. P.; Streltsova, Z.; Lee, S. W.; Devlin, M.; DeOliveira, D. B.; Enright, J.; Kent, R. B.; Wescott, C. R.; Ransohoff, T. C.; Ley, A. C.; Ladner, R. C. Biotechnol. Prog. 2002, 18, 182-192.
19. Enright, J.; Kent, R. B.; Wescott, C. R.; Ransohoff, T. C.; Ley, A. C.; Ladner, R. C. Development of mammalian serum albumin affinity purification media by peptide phage display. Biotechnol. Prog. 2002, 18, 182-192. (Pubitemid 34294225)
20. Ellis, L. M.; Hicklin, D. J. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 2008, 8, 579-591.
21. Shrivastava, A.; von Wronski, M.; Sato, A. K.; Dransfield, D. T.; Sexton, D.; Bogdan, N.; Pillai, R.; Nanjappan, P.; Song, B.; Marinelli, M.; DeOliveira, D.; Luneau, C.; Devlin, D.; Muruganandam, M.; Abujoub, A.; Connelly, G.; Wu, Q.; Conley, G.; Chang, Q.; Tweedle, M. F.; Ladner, R. C.; Swenson, R. E.; Nunn, A. D. A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases. Protein Eng., Des. Sel. 2005, 18, 417-424. (Pubitemid 41219888)
22. Pillai, R.; Marinelli, E. R.; Swenson, R. E. A flexible method for preparation of peptide homo- and heterodimers functionalized with affinity probes, chelating ligands, and latent conjugating groups. Pept. Sci. 2006, 84, 576-585. (Pubitemid 44935257)
23. Wiesmann, C.; Fuh, G.; Christinger, H. W.; Eigenbrot, C.; Wells, J. A.; de Vos, A. M. Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor. Cell 1997, 91, 695-704. (Pubitemid 27513660)
24. Klibanov, A. L. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv. Drug Delivery Rev. 1999, 37, 139-157. (Pubitemid 29164505)
25. Klibanov, A. L. Ultrasound molecular imaging with targeted microbubble contrast agents. J. Nucl. Cardiol. 2007, 14, 876-884. (Pubitemid 350082585)
26. von Wronski, M.; Raju, N.; Pillai, R.; Bogdan, N. J.; Marinelli, E. R.; Nanjappan, P.; Ramalingam, K.; Arunachalam, T.; Eaton, S.; Linder, K.; Yan, F.; Pochon, S.; Nunn, A. D.; Tweedle, M. F. Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of VEGF. J. Biol. Chem. 2006, 281, 5702-5710.
27. 99mTc-RP128 as a potential inflammation imaging agent: Human dosimetry and first clinical results. J. Nucl. Med. 2001, 42, 154-161. (Pubitemid 32104794)
28. Raju, N.; Ranganathan, R. S.; Tweedle, M. F.; Swenson, R. E. A new dendrimer scaffold for preparing dimers or tetramers of biologically active molecules. Tetrahedron Lett. 2005, 46, 1463-1465. (Pubitemid 40215044)
29. Tweedle, M. F. Adventures in multivalency - The Harry Fischer Memorial Lecture. Contrast Media Mol. Imaging 2006, 1, 2-9.
30. Vander Kooi, C. W.; Jusino, M. A.; Perman, B.; Neau, D. B.; Bellamy, H. D.; Leahy, D. J. Structural basis for ligand and heparin binding to neuropilin B domains. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 6152-6157. (Pubitemid 47186064)
31. Geretti, E.; Shimizu, A.; Klagsbrum, M. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 2008, 11, 31-39.
32. 121 and regulates endothelial cell migration and sprouting. J. Biol. Chem. 2007, 282, 24049-24052. (Pubitemid 47328044)
33. von Wronski, M.; Raju, N.; Bogdan, N. J.; Fox, J.: Lantry, L. E.; Tweedle, M. F.; Nunn, A. D. Anti-neuropilin-1 antibodies block the binding of a tuftsin-antagonist peptide, TKPPR, to neuropilin-1 in mice and on receptor-positive cells, Presented at the Joint Molecular Imaging Conference, 2007, abstract no. 0164.
34. Von Wronski, M.; Raju, N.; Tweedle, M. F.; Nunn, A. D. Subcellular localization of neuropilin-1 on endothelial cells with peptide-targeted quantum dots, Presented at the American Association for Cancer Research meeting, 2008, abstract no. LB-197.